Literature DB >> 8910459

Association of N-acetylgalactosamine-6-sulfate sulfatase with the multienzyme lysosomal complex of beta-galactosidase, cathepsin A, and neuraminidase. Possible implication for intralysosomal catabolism of keratan sulfate.

A V Pshezhetsky1, M Potier.   

Abstract

N-Acetylgalactosamine-6-sulfate sulfatase (GALNS) catalyzes the first step of intralysosomal keratan sulfate (KS) catabolism. In Morquio type A syndrome GALNS deficiency causes the accumulation of KS in tissues and results in generalized skeletal dysplasia in affected patients. We show that in normal cells GALNS is in a 1.27-MDa complex with three other lysosomal hydrolases: beta-galactosidase, alpha-neuraminidase, and cathepsin A (protective protein). GALNS copurifies with the complex by different chromatography techniques: affinity chromatography on both cathepsin A-binding and beta-galactosidase-binding columns, gel filtration, and chromatofocusing. Anti-human cathepsin A rabbit antiserum coprecipitates GALNS together with cathepsin A, beta-galactosidase, and alpha-neuraminidase in both a purified preparation of the 1. 27-MDa complex and crude glycoprotein fraction from human placenta extract. Gel filtration analysis of fibroblast extracts of patients deficient in either beta-galactosidase (beta-galactosidosis) or cathepsin A (galactosialidosis), which accumulate KS, demonstrates that the 1.27-MDa complex is disrupted and that GALNS is present only in free homodimeric form. The GALNS activity and cross-reacting material are reduced in the fibroblasts of patients affected with galactosialidosis, indicating that the complex with cathepsin A may protect GALNS in the lysosome. We suggest that the 1.27-MDa complex of lysosomal hydrolases is essential for KS catabolism and that the disruption of this complex may be responsible for the KS accumulation in beta-galactosidosis and galactosialidosis patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910459     DOI: 10.1074/jbc.271.45.28359

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  Mucopolysaccharidosis IVA and glycosaminoglycans.

Authors:  Shaukat Khan; Carlos J Alméciga-Díaz; Kazuki Sawamoto; William G Mackenzie; Mary C Theroux; Christian Pizarro; Robert W Mason; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2016-11-29       Impact factor: 4.797

2.  Molecular mechanism of lysosomal sialidase deficiency in galactosialidosis involves its rapid degradation.

Authors:  M V Vinogradova; L Michaud; A V Mezentsev; K E Lukong; M El-Alfy; C R Morales; M Potier; A V Pshezhetsky
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

Review 3.  Lysosomal multienzyme complex: pros and cons of working together.

Authors:  Erik J Bonten; Ida Annunziata; Alessandra d'Azzo
Journal:  Cell Mol Life Sci       Date:  2013-12-15       Impact factor: 9.261

4.  Identification of Selective Nanomolar Inhibitors of the Human Neuraminidase, NEU4.

Authors:  Amgad Albohy; Yi Zhang; Victoria Smutova; Alexey V Pshezhetsky; Christopher W Cairo
Journal:  ACS Med Chem Lett       Date:  2013-05-07       Impact factor: 4.345

5.  Molecular mechanisms of pathogenesis in a glycosphingolipid and a glycoprotein storage disease.

Authors:  Alessandra d'Azzo; Erik Bonten
Journal:  Biochem Soc Trans       Date:  2010-12       Impact factor: 5.407

Review 6.  Recent development in mammalian sialidase molecular biology.

Authors:  Eugenio Monti; Augusto Preti; Bruno Venerando; Giuseppe Borsani
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

7.  Regulation of phagocytosis in macrophages by neuraminidase 1.

Authors:  Volkan Seyrantepe; Alexandre Iannello; Feng Liang; Evgeny Kanshin; Preethi Jayanth; Suzanne Samarani; Myron R Szewczuk; Ali Ahmad; Alexey V Pshezhetsky
Journal:  J Biol Chem       Date:  2009-11-04       Impact factor: 5.157

8.  Cell-permeable probe for identification and imaging of sialidases.

Authors:  Charng-Sheng Tsai; Hsin-Yung Yen; Meng-I Lin; Tsung-I Tsai; Shi-Yun Wang; Wen-I Huang; Tsui-Ling Hsu; Yih-Shyun E Cheng; Jim-Min Fang; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

9.  Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels.

Authors:  Vũ Chí Dũng; Shunji Tomatsu; Adriana M Montaño; Gary Gottesman; Michael B Bober; William Mackenzie; Miho Maeda; Grant A Mitchell; Yasuyuki Suzuki; Tadao Orii
Journal:  Mol Genet Metab       Date:  2013-06-26       Impact factor: 4.797

10.  Molecular testing of 163 patients with Morquio A (Mucopolysaccharidosis IVA) identifies 39 novel GALNS mutations.

Authors:  A Morrone; K L Tylee; M Al-Sayed; A C Brusius-Facchin; A Caciotti; H J Church; M J Coll; K Davidson; M J Fietz; L Gort; M Hegde; F Kubaski; L Lacerda; F Laranjeira; S Leistner-Segal; S Mooney; S Pajares; L Pollard; I Ribeiro; R Y Wang; N Miller
Journal:  Mol Genet Metab       Date:  2014-03-20       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.